Skip to main content
. Author manuscript; available in PMC: 2020 Dec 1.
Published in final edited form as: Cortex. 2019 Oct 2;121:362–384. doi: 10.1016/j.cortex.2019.09.005

Table 1.

Demographic and clinical features of the Parkinson’s and control groups.

PD patients Controls
Age 67.93 (7.71) 69.56 (8.06)
Education 16.9 (2.04) 17.74 (3.17)
Gender 23 M,18 F 15 M,24 F
MOCA 28.05 (1.48) 27.95 (1.47)
PD patients
Disease Duration (years) 7.8 (4.13)
UPDRS-Motor subscale 24.2 (9.48)
Hoehn and Yahr staging Stage 1: 1
Stage 2: 28
Stage 3: 11
Stage 4: 0
Stage 5: 1
Levodopa Equivalent Dose 721.95 (404.51)